ZIRGAN

*Study design: 164 patients participated in a phase 3, open-label, randomized, controlled trial of ZIRGAN vs acyclovir (3%). Dosing was 5 times a day until the ulcer healed and then 3 times a day for one week. 77% of ZIRGAN-treated patients had healed ulcers defined as the clinical disappearance of the ulcer at day 7 compared with 72% of acyclovir-treated patients. ZIRGAN was noninferior to acyclovir in patients with dendritic ulcers. 2,3... ZIRGAN® (ganciclovir ophthalmic gel) 0.15% is a topical ophthalmic antiviral that is indicated for the treatment of acute herpetic keratitis (dendritic ulcers)... Learn about Bausch + Lomb's ZIRGAN® gel, a topical ophthalmic antiviral indicated for the treatment of acute herpetic keratitis (dendritic ulcers). Find MOA, dosing information, prescription savings more.